The actions of 5-hydroxytryptamine receptor agonists and antagonists at pre- and postjunctional level on the canine saphenous vein
- PMID: 2977424
- DOI: 10.1007/BF00165625
The actions of 5-hydroxytryptamine receptor agonists and antagonists at pre- and postjunctional level on the canine saphenous vein
Abstract
The prejunctional and postjunctional 5-HT receptors of the canine saphenous vein were studied. The release of 3H-noradrenaline (3H-NA) from incubated saphenous vein strips was inhibited by 5-hydroxytryptamine (5-HT) in a concentration-dependent way (5-HT concentrations: 0.01, 0.1 and 1.0 mumol.l-1), but not by the selective 5-HT1A agonist 8-hydroxy-dipropylaminotetralin (8-OH-DPAT; 1 and 10 mumol.l-1). The inhibitory effect of 5-HT was antagonized by metitepine and methysergide, but not by yohimbine, (-)-pindolol or ketanserin. In strips preincubated with 5-HT (1.2 mumol.l-1), the fractional release of 3H-NA was slightly reduced (paired experiments). 5-HT and 8-OH-DPAT caused concentration-dependent contractions of the saphenous smooth muscle. A parallel shift of the concentration-response curve for 8-OH-DPAT to the right was caused by metitepine and yohimbine, but not by ketanserin. The contractions caused by 5-HT were antagonized by metitepine and yohimbine (parallel displacement of the curves to the right), as well as by ketanserin and methysergide (with a depression of the upper part of the curve). Blockade of alpha-adrenoceptors (due to prazosin plus a low concentration of yohimbine) also resulted in a weak antagonistic effect. Ketanserin and metitepine displaced the noradrenaline concentration-response curve to the right. We conclude that the saphenous vein of the dog is endowed with prejunctional receptors of the 5-HT1 type which can not be classified as belonging either to the 1A or 1B subtype; and that at the postjunctional level 5-HT1 (possibly of the 1D subtype) and 5-HT2 receptors are present.(ABSTRACT TRUNCATED AT 250 WORDS)
Similar articles
-
Vascular 5-HT1-like receptors that mediate contraction of the dog isolated saphenous vein and carotid arterial vasoconstriction in anaesthetized dogs are not of the 5-HT1A or 5-HT1D subtype.Br J Pharmacol. 1991 Jan;102(1):191-7. doi: 10.1111/j.1476-5381.1991.tb12152.x. Br J Pharmacol. 1991. PMID: 1675143 Free PMC article.
-
Inhibitory presynaptic 5-hydroxytryptamine (5-HT) receptors on the sympathetic nerves of the human saphenous vein.Naunyn Schmiedebergs Arch Pharmacol. 1986 Apr;332(4):317-23. doi: 10.1007/BF00500081. Naunyn Schmiedebergs Arch Pharmacol. 1986. PMID: 2942782
-
5-Hydroxytryptamine(1A) receptor activation enhances norepinephrine release from nerves in the rabbit saphenous vein.J Pharmacol Exp Ther. 1999 Sep;290(3):1195-201. J Pharmacol Exp Ther. 1999. PMID: 10454495
-
Mechanisms involved in serotonin-induced vasodilatation.Blood Vessels. 1990;27(2-5):116-26. doi: 10.1159/000158802. Blood Vessels. 1990. PMID: 2242440 Review.
-
Serotonergic Modulation of Neurovascular Transmission: A Focus on Prejunctional 5-HT Receptors/Mechanisms.Biomedicines. 2023 Jun 29;11(7):1864. doi: 10.3390/biomedicines11071864. Biomedicines. 2023. PMID: 37509503 Free PMC article. Review.
Cited by
-
Effects of U46619 on contractions to 5-HT, sumatriptan and methysergide in canine coronary artery and saphenous vein in vitro.Br J Pharmacol. 1995 Oct;116(4):2183-90. doi: 10.1111/j.1476-5381.1995.tb15052.x. Br J Pharmacol. 1995. PMID: 8564247 Free PMC article.
-
Venoconstrictor responses to dihydroergocristine and dihydroergotamine: evidence for the involvement of 5-HT1 like receptors.Cardiovasc Drugs Ther. 1990 Dec;4(6):1455-60. doi: 10.1007/BF02026491. Cardiovasc Drugs Ther. 1990. PMID: 2127899
-
Effects of 6-hydroxydopamine on pre- and post-junctional 5-HT1-like receptor-mediated responses in dog saphenous vein.Naunyn Schmiedebergs Arch Pharmacol. 1993 Mar;347(3):257-65. doi: 10.1007/BF00167443. Naunyn Schmiedebergs Arch Pharmacol. 1993. PMID: 8386806